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Abstract
Background Regular physical activity is the prime modality for the prevention of numerous non-communicable diseases and 
has also been advocated for resilience against COVID-19 and other infectious diseases. However, there is currently no system-
atic and quantitative evidence synthesis of the association between physical activity and the strength of the immune system.
Objective To examine the association between habitual physical activity and (1) the risk of community-acquired infectious 
disease, (2) laboratory‐assessed immune parameters, and (3) immune response to vaccination.
Methods We conducted a systemic review and meta-analysis according to PRISMA guidelines. We searched seven databases 
(MEDLINE, Embase, Cochrane CENTRAL, Web of Science, CINAHL, PsycINFO, and SportDiscus) up to April 2020 for 
randomised controlled trials and prospective observational studies were included if they compared groups of adults with 
different levels of physical activity and reported immune system cell count, the concentration of antibody, risk of clinically 
diagnosed infections, risk of hospitalisation and mortality due to infectious disease. Studies involving elite athletes were 
excluded. The quality of the selected studies was critically examined following the Cochrane guidelines using ROB2 and 
ROBINS_E. Data were pooled using an inverse variance random-effects model.
Results Higher level of habitual physical activity is associated with a 31% risk reduction (hazard ratio 0.69, 95% CI 0.61–
0.78, 6 studies, N = 557,487 individuals) of community-acquired infectious disease and 37% risk reduction (hazard ratio 
0.64, 95% CI 0.59–0.70, 4 studies, N = 422,813 individuals) of infectious disease mortality. Physical activity interventions 
resulted in increased CD4 cell counts (32 cells/µL, 95% CI 7–56 cells/µL, 24 studies, N = 1112 individuals) and salivary 
immunoglobulin IgA concentration (standardised mean difference 0.756, 95% CI 0.146–1.365, 7 studies, N = 435 individu-
als) and decreased neutrophil counts (704 cells/µL, 95% CI 68–1340, 6 studies, N = 704 individuals) compared to controls. 
Antibody concentration after vaccination is higher with an adjunct physical activity programme (standardised mean differ-
ence 0.142, 95% CI 0.021–0.262, 6 studies, N = 497 individuals).
Conclusion Regular, moderate to vigorous physical activity is associated with reduced risk of community-acquired infec-
tious diseases and infectious disease mortality, enhances the first line of defence of the immune system, and increases the 
potency of vaccination.
Protocol registration The original protocol was prospectively registered with PROSPERO (CRD42020178825).
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Key Points 
Engaging regularly in moderate to vigorous physi-
cal activity is associated with a 31% risk reduction of 
community-acquired infectious disease and 37% risk 
reduction in infectious disease mortality
Engaging regularly in moderate to vigorous physical 
activity is associated with the increased strength of the 
mucosal immune barrier (salivary IgA immunoglobulin) 
and higher concentration of immune cells that prepare, 
orchestrate, regulate and effect immunity (CD4 T-cells)
Engaging regularly in moderate to vigorous physical 
activity could strengthen the effect of vaccination cam-
paigns
1 Introduction
Lower respiratory tract infections and pneumonia account for 
more than 4 million deaths annually and upper respiratory 
infections rank as the leading incident disease in the world 
[1]. These infections are caused by viruses or a combination 
of viral and bacterial invasion. They can be very contagious 
and spread rapidly leading to epidemics and pandemics as 
in the case of SARS-CoV-2 (COVID-19). There are numer-
ous public health strategies to cope with pandemics [2]. An 
important approach to containing the recent SARS-CoV-2 
(COVID-19) outbreak has been the requirement of com-
munities to remain at home (“lockdown”) thereby reducing 
social contact and containing the spread of the virus. Despite 
these restrictions, numerous governments underlined the 
importance of remaining physically active for health and 
wellbeing [3], and recognised the necessity to allow indi-
viduals to leave their home to walk, cycle or run.
Regular physical activity is associated with the preven-
tion of numerous non-communicable diseases [4]. Physical 
activity may also have important functions in a pandemic 
and in the prevention of infectious diseases. Firstly, it has 
been hypothesised that physically active people are likely 
to be more resilient to infection through better immuno-
surveillance against pathogens [5]. Secondly, given that 
severe infections are more likely in individuals with poorer 
cardiovascular and metabolic health and who might have 
pre-existing chronic conditions, we might hypothesise that 
physical activity also has an indirect protective effect against 
infectious disease by improving cardiovascular and meta-
bolic health and lowering the risk of chronic diseases [6, 
7]. Third, there is a suggestion that physical activity is also 
associated with a more favourable response to vaccination 
[6]; thus acquired immunity could be greater in a physically 
active population.
Some have advocated the importance of physical activity 
for resilience against COVID-19 [6, 8–11]. Strong claims 
have been made in support of physical activity and its thera-
peutic effects on immunity [5] but as yet, there has been no 
attempt to systematically evaluate the current evidence on 
the effect of habitual physical activity on laboratory‐assessed 
immune parameters, and risk of community-acquired infec-
tious disease for the general population based on objective 
markers. A number of narrative reviews have debated the 
effect of physical activity on human immunity [5, 12] but 
the majority of this literature is devoted to the acute effect of 
exercises and focuses on athletes. Some reviews and meta-
analysis have evaluated the impact of exercise on the risk 
of self-reported upper respiratory tract infection, but these 
were inconclusive due to a low level of evidence and very 
few available studies [13, 14].
There is a need for clear evidence, based on objective 
markers, on the importance of engaging in regular physical 
activity for the general population that will help develop a 
policy for the ongoing COVID-19 outbreak. This will be 
crucial to help populations better fight this virus during a 
possible future wave, maximise responses to vaccination 
programmes when available, and inform preparation for 
future pandemics.
We aimed to perform a meta-analysis of randomised con-
trolled trials (RCTs) and prospective studies to answer the 
following questions:
1. Does engaging in habitual physical activity decrease 
the risk of community-acquired infectious disease and 
related mortality?
2. Does engagement in physical activity improve immuno-
surveillance and response?
3. Does engagement in physical activity increase the effect 
of immunisation?
2  Methods
We conducted this systematic review and meta-analysis 
according to the PRISMA guidelines [15]. We prospectively 
registered the review with PROSPERO (CRD42020178825) 
but made alterations (described below) to focus this meta-
analysis on the chronic effect of physical activity.
2.1  Search Strategy
We searched seven databases: MEDLINE, Embase, 
Cochrane CENTRAL, Web of Science, CINAHL, Psy-
cINFO, and SportDiscus from January 1980 until 14 April 
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2020 for peer-reviewed journal articles published in the Eng-
lish language. The search strategy is presented in Electronic 
Supplementary Material (ESM) Table S1. In addition, we 
complemented the search by scanning the reference list of 
full texts included and relevant systematic reviews.
2.2  Criteria for Considering Studies for This Review
2.2.1  Types of Studies
We included observational studies (prospective cohort 
studies) and RCTs including cluster RCTs in humans. We 
excluded controlled before-after (CBA) and non-randomised 
experimental studies, qualitative studies, reviews, opinion 
pieces and cross-sectional and case controlled observational 
studies. If studies had duplicated data, we included only one 
study. We selected this based on risk of bias, sample size and 
date of publication. We excluded animal studies.
2.2.2  Types of Participants/Population
We included studies with adult participants who were 
≥ 18 years. We excluded studies that compared outcomes in 
athletes and highly trained sports men and women, as such 
individuals undertake volumes and intensities of training 
unrepresentative of the general population.
2.2.3  Types of Interventions/Exposure
We included studies examining levels of habitual physical 
activity or regular exercise programmes. Studies where par-
ticipants received multiple interventions were only included 
if the only difference between the groups was the physical 
activity intervention. We excluded studies that only used 
physical activity as a confounding variable or that did 
not present data on physical activity separately. We also 
excluded studies assessing the effect of a single bout of exer-
cise or exercise session.
2.2.4  Comparator
We included studies that had no physical activity or a lesser 
volume, duration, frequency, or intensity of physical activity 
as a comparator.
2.2.5  Types of Outcome Measures
We focussed on chronic response to physical activity and 
excluded studies which reported only acute response to 
exercise. We included studies that reported objective meas-
urement of at least one of these outcomes: immune system 
cell count such as white blood cell count, concentration of 
antibodies considered markers of depressed immune system, 
risk of clinically diagnosed infections (recorded by clini-
cian), risk of clinically recorded complications (hospitalisa-
tion, mortality). We specifically excluded studies exclusively 
concerned with cytokines (interleukin-6), C-reactive protein 
(CRP), tissue necrotic factors, and other markers of inflam-
matory responses which are not immune cells. There are 
already several meta-analyses on the relationship between 
physical activity and inflammatory markers [16, 17]. We 
also excluded studies which used a self-reported measure 
of infection, hospitalisation or sequelae such as patients’ 
self-reported symptoms of upper respiratory tract infections.
2.3  Screening
We imported the studies identified from the search into 
COVIDENCE (Veritas Health Innovation) to remove dupli-
cates and for transparent management of the review by the 
team. Two review authors (from a pool of 11) independently 
screened studies and judged their eligibility for inclusion in 
the review. We resolved disagreements by discussion and 
consultation with a third review author when needed. We 
sought additional information from authors of studies when 
the information was inadequate to determine eligibility in 
the review.
2.4  Data Extraction
Two review authors (from the same pool of 11) indepen-
dently extracted data and resolved disagreements on data 
extraction including the results in the review, by discussion 
among the review team. When details were missing, we con-
tacted the authors of the study to obtain the information.
2.5  Assessment of Risk of Bias and Quality 
of Evidence Rating
Two authors from the same pool of 11 independently 
assessed the risk of bias in included studies with disagree-
ment resolved by discussion or additional consultation with a 
third review author. We used ROB2 [18] to assess the risk of 
bias in RCTs and ROBINS-E [19] for observational studies.
2.6  Quantitative Synthesis
We conducted separate meta-analyses for each outcome 
of RCTs and observational studies when studies provided 
outcome data in comparable units or effect size that could 
be pooled. We stratified the analysis by population groups 
when sufficient studies were available. These groups 
included healthy adults, obese individuals, older adults (aged 
60 years and over) and clinical populations particularly at 
risk of infectious diseases such as HIV, organ transplant, and 
cancer patients. We computed the pooled effect size using 
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random effect models as we hypothesised that a range of true 
effects was likely. For RCTs, we used the post-trial values 
for exercise and control groups rather than pre-post effect 
size to minimise bias [20]. When studies reported more 
than one-time point, we used data recorded immediately 
post-intervention. If trials included more than one inter-
vention group, we included each intervention in a separate 
comparison. We divided the number of participants in the 
control group accordingly to avoid double counting [21]. 
When measurement methods of the outcome were similar, 
we computed the unstandardised mean difference (MD) in 
immune cell concentration. Otherwise, we calculated the 
standardised mean difference (SMD). However, if only a 
small minority of studies reported in different units, we 
favoured reporting the mean difference and excluded these 
studies. Heterogeneity was measured using I2 statistics. We 
assessed publication bias by inspecting funnel plots visu-
ally. When sufficient studies were available, we conducted 
meta-regression to estimate the moderating effect of fre-
quency, intensity, type (aerobic or resistance training) and 
duration of physical programmes and to identify sources of 
heterogeneity. Finally, we conducted a sensitivity analysis 
to ascertain the robustness of the results. All meta-analyses 
were performed with random effect models using the Com-
prehensive Meta-Analysis Software (Version 3.3.07, Biostat, 
Englewood NJ).
2.7  Deviation from Registered Protocol
This systematic review and meta-analysis includes some 
deviations and changes compared to the initial protocol 
registered on PROSPERO. The initial protocol was very 
ambitious and designed to synthesise all aspects of current 
research on the relationship between physical activity and 
human immunity and provide detailed quantitative synthesis 
to inform public health measures. The study was narrowed 
to focus on research on the chronic effect of regular physical 
activity as this is more directly relevant to population health 
using the highest level of evidence. Consequently, the fol-
lowing changes were made:
• Review questions: aim to synthesise the acute effect of 
physical activity was abandoned to focus the review on 
chronic effects of regular physical activity.
• Eligible studies: design was restricted to RCTs for experi-
mental studies and prospective studies for observational 
studies as they constitute the highest level of evidence.
• Population: studies on elite athlete and highly trained 
individuals were excluded to focus on information more 
directly relevant to the general population who mostly 
engage in a low level of physical activity.
• Interventions: studies on single bouts of exercise were 
excluded to focus the review on information about regu-
lar physical activity.
• Outcomes: the list of outcomes was narrowed to objec-
tive markers of the immune system (cell counts) and 
objective records of infection and death due to infectious 
disease. Thus, for example, self-reported cases of upper 
respiratory tract infection were excluded.
• Risk of bias: we used risk of bias tools more widely rec-
ognised and more specific to the design included rather 
than a generic tool (Qualsys).
• Sub-group analysis: additional sub-group analyses were 
conducted (obesity, clinical populations) to analyse het-
erogeneity and understand the potential modifying effect 
of well known factors for which data existed.
3  Results
3.1  Study Characteristics
The systematic search information flow is depicted in Fig. 1. 
The primary search returned 16,698 records, and an addi-
tional 135 were added through secondary manual searches. 
After screening, 606 full texts were read and assessed for 
inclusion. A total of 551 articles were excluded mainly 
because of the study design not meeting the inclusion cri-
teria. After eligibility assessment 55 studies consisting 
of seven observational prospective studies and 48 RCTs 
(including six studies focussed on vaccination) met the 
inclusion criteria. The characteristics of these studies are 
given in ESM Tables S2–S4.
3.2  Risk of Bias
We classified six observational studies as being at moder-
ate risk of bias and one at high risk because they used the 
self-reported method to measure physical activity, contained 
limited adjustment for important covariates, lacked sensi-
tivity analyses (e.g., to explore reverse causation) and did 
not include reporting of missing data (ESM Table S5). We 
judged 20 RCTs as being at moderate risk of bias and 12 
at high risk because of poor randomisation, selection bias 
and poor reporting and management of missing data. The 
remaining 10 were at low risk (ESM Table S6). For vaccina-
tion studies, two were low risk while two were at moderate 
risk of bias and two at high risk because of selection bias and 
overall design issues. Details of quality assessment in each 
domain are given in ESM (Tables S5, S6 and S7).
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3.3  Synthesis
3.3.1  Observational Studies
Six observational studies could be meta-analysed [22–28]. 
Neuman et al. [28] and Baik et al. [22] reported on the same 
cohort and we included only Baik et al. [22] in the meta-
analysis because it had a larger sample size from combin-
ing two cohorts. The pooled effect showed a statistically 
significant 31% risk reduction (hazard ratio [HR] 0.69 95% 
CI [0.61–0.78], I2 = 20.4%) for community-acquired infec-
tious disease for people engaging in levels of regular physi-
cal activity equal or over the recommended 150 min per 
week compared to those below that level (Fig. 2a) based on 
a total sample of N = 557,487 individuals. The risk of infec-
tious disease mortality (mostly pneumonia) was reduced by 
37% (HR 0.64 95% CI [0.59–0.70], I2 = 40.0%) for individu-
als who met the recommended physical activity guidelines 
compared to individuals who did not meet the guidelines 
(Fig. 2b) based on a total sample of N = 422,813 individuals.
3.3.2  Physical Activity and Laboratory‐Assessed Immune 
Parameters
3.3.2.1 White Blood Cell Count (Leukocytes) Ten studies 
(N = 384 individuals) [29–38] reported on total white blood 
cell count after a physical activity intervention programme 
involving 15–120  min (median 30  min) of moderate to 
Fig. 1  Preferred reporting items 
for systematic reviews and 
meta-analysis (PRISMA) flow 
diagram
Records idenfied through database 
searching
(n =16698)
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vigorous intensity aerobic training (n = 7 studies, walking, 
running or cycling) or a combination of aerobic and resist-
ance training (n = 3 studies) delivered 3–5 times per week 
and lasting from 4 to 26 weeks (median 12 weeks). There 
was no effect of physical activity interventions compared to 
control with a pooled overall lower white blood cell count 
of 519 cells/µL (95% CI [− 11 to 1049], p = 0.055) (ESM 
Figure S1). The heterogeneity between studies was moder-
ate, I2 = 47.9%.
3.3.2.2 Innate Immune System Cell Counts In total, 16 
studies [29, 30, 32, 34–37, 39–47] reported on innate 
immune system cell count after a physical activity interven-
tion programme involving 15–120 min (median 45 min) of 
moderate to vigorous intensity aerobic training (n = 4 stud-
ies, walking, running or cycling) [39–41, 46] or a combina-
tion of aerobic and resistance training (n = 2 studies) [35, 
43] delivered 1–5 times per week (median 3) and lasting 
from 4 to 26 weeks (median 12 weeks). There was a sta-
tistically significant effect of physical activity interven-
tions (ESM Figure S2) compared to control with a pooled 
lower neutrophil count of 704  cells/µL (95% CI [−  1340 
to −  68], p = 0.030, I2 = 50.2%) for N = 305 individuals, 
but not for monocytes (MD = 18  cells/µL 95% CI [−  18 
to 54], p = 0.325, I2 = 50.2%, N = 185 individuals) or NK 
cells (MD = − 15 cells/µL 95% CI [− 47 to 18], p = 0.378, 
I2 = 46.5%, N = 461 individuals).
3.3.2.3 Adaptive Immune System Total lymphocytes Two 
studies investigated the effect of resistance training [48, 49], 
three combined resistance and aerobic (walking, cycling) 
physical activity [31, 32, 35] and all other studies used 
aerobic physical activity intervention only. Training pro-
grammes involved moderate to vigorous intensity activities 
for a minimum of 30 min twice a week and lasted between 
4 and 26 weeks (median 8 weeks). There was a statistically 
significant effect of physical activity intervention compared 
to control with a pooled lower total lymphocyte count of 
– 244 cells/µL (95% CI [− 475 to 13], p = 0.038) for healthy 
adults, but not in other groups or overall (MD = − 60 cells/
µL, 95% CI [− 277 to 157], p = 0.589, I2 = 41.8%, N = 498 
individuals) (ESM Figure S3).
T cells (CD3+) Training in these studies had a median fre-
quency of 5 sessions per week, median duration of 40 min, 
lasting between 1 and 26 weeks (median 10 weeks) and 
involved aerobic activity (n = 7), resistance training (n = 5) 
and combined aerobic and resistance interventions (n = 4). 
There was no statistically significant effect of physical activ-
ity intervention (MD = − 111 cells/µL (95% CI [− 225 to 4], 
p = 0.059, I2 = 26.8%, N = 751 individuals) (Fig. 3a).
T cell helpers (CD4+) Training in these 24 studies had 
a median frequency of 3 sessions per week, median dura-
tion of 40 min, lasting between 1 and 26 weeks (median 
10 weeks) and involved aerobic activity (n = 10), resistance 
training (n = 9) and combined aerobic and resistance activ-
ity (n = 6) at light to vigorous intensity. The meta-analysis 
(Fig. 3b) showed a statistically significant effect of physi-
cal activity intervention compared to control with a pooled 
higher T cell (CD4+) count of 32 cells/µL (95% CI [7–56], 
p = 0.011, I2 = 33.0%, N = 1112 individuals) overall and the 
same for clinical populations (MD = 37 cells/µL (95% CI 
[7–66], p = 0.013).
T cells cytotoxic (CD8+) Median characteristics for 
the studies reporting on the CD8+ lymphocytes sub-pop-
ulation were 3 sessions/week of 40 min for 8 weeks and 
involved resistance training (n = 8), aerobic activity (n = 9) 
Fig. 2  Forest plot for obser-
vational studies. a Risk of 
community-acquired infection, 
b risk of infectious disease 
mortality. Size of the square 
represent the weight of each 
study in the meta-analysis
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Fig. 3  Forest plot for T cell 
counts: a CD3+, b CD4+ and 
c CD8+ for healthy adults, 
clinical groups, obese adults 
and older adults (OA). Mean 
difference (MD) is in cell/pL. 
Size of the square represent 
the weight of each study in the 
meta-analysis
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or a combination of both (n = 3). The meta-analysis (which 
excluded seven studies which reported in different units 
[30, 46, 48, 50–53]) showed no significant effect of physi-
cal activity interventions compared to control for CD8+ 
count (MD = − 44 cells/µL, 95% CI [− 90 to 2], p = 0.058, 
I2 = 8.1%, N = 896 individuals). However, there was a sta-
tistically significant difference for clinical populations with 
lower CD8+ count of – 78 cells/µL (95% CI [− 140 to − 16], 
p = 0.014) (Fig. 3c).
3.3.2.4 Immunoglobulin Our meta-analyses (Fig.  4) 
showed a statistically significant effect of physical activ-
ity interventions (median characteristics: 3 times per 
week, moderate to vigorous intensity, 30 min in length for 
15  weeks) on salivary IgA concentration overall (SMD 
0.756 95% CI [0.146–1.365], p < 0.015, I2 = 84.3%, N = 435 
individuals). No statistically significant effect of physical 
activity was detected for serum IgA, IgG or IgM (ESM Fig-
ure S4).
3.3.3  Vaccination Studies
Six studies (N = 497 individuals) investigated the effect of 
physical activity interventions on the outcomes of vaccina-
tion and reported differences in antibody titres for H1N1, 
H3N2, influenza type B [54–57], pneumococcal [58] and 
varicella zoster virus [59]. The median characteristics of 
the training programme were 3 sessions per week of 60 min 
for 20 weeks prior to vaccination involving aerobic or com-
bined aerobic and strengthening exercises [55]. Pooled 
effects showed a statistically significant effect of physical 
activity compared to control with higher antibody titres 
(SMD = 0.142 95% CI [0.021–0.262], p = 0.022, I2 = 0.00%) 
(Fig. 5).
3.4  Heterogeneity, Publication Bias, Sensitivity 
Analysis and Influence of Intervention 
Characteristics
We observed no discernible signs of publication bias (ESM 
Figures S5 to S15) for any of the outcomes considered. Het-
erogeneity was low to moderate for most outcomes but high 
for salivary IgA. Sensitivity analysis, taking into account 
the quality of the studies, did not change the results signifi-
cantly. Meta-regression did not show statistically significant 
trends or moderating effects of physical activity intervention 
characteristics (frequency, intensity, time, type and duration) 
or sub-population group for any of the outcomes. We could 
not identify a specific source of heterogeneity. None of the 
intervention characteristics or population subgroups explain 
observed heterogeneities. The heterogeneity is likely to be 
due to a combination of factors including the measurement 
methods, heterogeneity in the samples, and compliance with 
physical activity programmes.
4  Discussion
Previous reviews and meta-analyses of the role of physi-
cal activity in immunity and risk of infectious disease were 
based on the risk of self-reported upper respiratory tract 
infection and proved inconclusive due to a low level of evi-
dence and the very small number of published studies [13, 
14]. In contrast, this meta-analysis which focuses on objec-
tive markers and includes a larger number of studies pro-
vides some clear and consistent results. This meta-analysis 
shows that higher levels of habitual physical activity are 
associated with a 31% lower prospective risk of infectious 
disease and 37% lower risk of infectious disease-related 
mortality.
We found evidence of significant changes in specific 
immune parameters as a result of regular physical activity. 
Fig. 4  Forest plot for immu-
noglobulin concentration of 
salivary IgA (SIgA) for healthy 
adults and older adults (OA). 
Size of the square represents 
the weight of each study in 
the meta-analysis. For studies 
with several arms, arms are 
indicated. SMD represented the 
standardised mean difference
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The physical activity interventions, lasting on average a 
median 12 weeks and including aerobic (walking, running, 
cycling) or resistance or combined aerobic and resistance 
activity delivered 3–5 times per week for an average of 
30 min at moderate to vigorous intensity, resulted overall 
in higher concentrations of CD4 T cell helpers and sali-
vary immunoglobulin IgA, and a lower concentration of 
neutrophils.
While the full role of CD4 T cells is not fully understood, 
they are thought to carry out a wide variety of functions 
within the immune system [73]. CD4 T cells are orchestra-
tors, regulators and direct effectors of the immune response. 
CD4 T cells play a role in immunosurveillance, continuously 
monitoring for pathogens. They induce an early inflamma-
tory response that contributes to a rapid and more robust 
immune response but also regulate this response and chronic 
inflammation. They enhance the response and memory of 
other immune cells but also are a direct effector mediating 
pathogen clearance [73, 74]. The elevated concentration of 
CD4 T cells found in this meta-analysis suggests that regu-
lar physical activity strengthens these functions within the 
immune system and results in a faster response.
The primary function of SIgA is to protect the mucosal 
surface against invasion by pathogens [75]. It can be 
regarded as the first line of defence of the immune system 
against external pathogens [76]. In addition, SIgA plays a 
variety of other roles and in particular, it acts as an anti-
inflammatory, down-regulating inflammation processes [77]. 
The higher concentration of SIgA shown by our meta-anal-
ysis indicates that regular physical activity also strengthens 
the mucosal barrier to pathogens and the body’s first line 
of defence.
Neutrophils are the most abundant white blood cells, are 
considered as the main effector of pathogen clearance and 
are the first white blood cells recruited upon infection. The 
observed decrease in neutrophil cell count associated with 
regular physical activity might, therefore, be interpreted in 
isolation as a sign that physical activity might depress the 
immune system. However, we did not observe a decrease in 
total white cell counts associated with regular physical activ-
ity and neutrophils play other roles within the immune sys-
tem [78]. In particular, neutrophils are involved in chronic 
inflammation and an elevated neutrophil count is often 
regarded as a marker of chronic inflammation. It is well 
established that regular physical activity is associated with 
reduced levels of chronic inflammation and concentrations 
of inflammation markers [79, 80]. Therefore, an alternative 
interpretation of the observed decreased level of neutrophils 
is that it is a consequence of the effect of regular physical 
activity on chronic inflammation. This is congruent with the 
observed increased concentrations of SIgA and CD4 as this 
might also increase their anti-inflammatory action. It is also 
consistent with a report on the effect of acute exercise [12].
Taken together there is evidence that regular moderate to 
vigorous physical activity might contribute to a more effec-
tive immune system and response providing enhanced pro-
tective immunity to infections. The strength of the immune 
system and its efficacy cannot be fully ascertained by 
immune cell count and antibody concentration alone. How-
ever, our results for laboratory‐assessed immune parameters 
are consistent with the observed significant reduction in risk 
Fig. 5  Forest plot for antibod-
ies titres after vaccination per 
vaccination type. Size of the 
square represents the weight of 
each study in the meta-analysis. 
SMD represented the standard-
ised mean difference
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of community-acquired infection in this meta-analysis and 
some previous reports on decreased risk of self-reported 
upper-respiratory tract infections [5, 81, 82]. Taken together 
it is logical to think there is evidence that regular moder-
ate to vigorous physical activity might contribute to a more 
effective immune system and response providing enhanced 
protective immunity to infections.
This suggests that people should be encouraged to 
engage in regular physical activity to strengthen their 
immune system, and decrease their risk of infectious dis-
ease and mortality related to infectious disease. Future pub-
lic health guidelines for physical activity should consider 
integrating evidence about the impact of physical activity 
on infectious disease as well as chronic diseases and make 
recommendations.
The current evidence base does not provide enough 
information to be very specific about how time, frequency, 
duration and type of physical activity influence the effect on 
immune defence to infectious disease. However, the level 
of physical activity recommended (150 min per week of 
moderate to vigorous physical activity combining aerobic 
and strengthening activity) by current guidelines [83] for 
prevention of chronic disease appears to be also protective 
against infectious disease and infectious disease mortality. 
It is likely that a dose–response relationship exists. This has 
been hypothesised previously [5, 12] based on epidemiologi-
cal studies of incidence of self-reported upper respiratory 
tract infection epidemiological studies. It is thought that 
this relationship has a J-shape with increased risk of infec-
tion with heavy exertion. The activity level associated with 
increased risk remains unclear. We found no evidence of 
detrimental effect of physical activity with increased volume 
or intensity in the general population and up to moderate to 
vigorous intensity and volume ranging from 60 to 600 min/
week. This suggests that within the general population, 
engaging in regular physical activity at any intensity up to 
moderate to vigorous activity is safe with respect to risk 
of infection. Consequently, future public health guidelines 
should integrate the protective benefit of physical activity 
against infectious diseases. This might help promote physi-
cal activity more effectively for prevention and management 
of outbreaks, epidemics and pandemics.
In addition, physical activity programmes could be used 
as an adjunct to vaccination campaigns because while a 
meta-analysis on the effect of acute exercise intervention on 
influenza immunisation was inconclusive [84], the present 
meta-analysis demonstrates that regular physical activity sig-
nificantly increases antibody levels after vaccination, includ-
ing in older adults. This is consistent with the conclusion 
of a narrative review of the effect of chronic exercise on 
immunisation [85]. The data suggest that regular physical 
activity programmes involving around 150 min per week of 
moderate to vigorous physical activity for 20 weeks prior to 
vaccination could be necessary.
The mechanism by which physical activity influences the 
immune system remains unclear and a matter of debate, but 
is likely to involve multiple pathways, both physiological and 
psychological [5, 86]. Physical activity is also well known to 
improve chronic conditions such as diabetes or obesity that 
increase the risk of severe complications and mortality due 
to infectious disease. In addition, physical activity is effec-
tive for stress management which in turn affects both the 
immune system and inflammatory responses [87].
4.1  Risk of Bias and Future Research
While the evidence base was overall of good quality with 
most studies being of moderate to low risk of bias, future 
research should seek to improve certain points. For observa-
tional studies, better reporting and treatment of confounding 
factors would improve the situation. In addition, the main 
limitation within observational studies was that physical 
activity was self-reported rather than objectively measured. 
Self-reported measures of physical activity tend to lead to 
attenuation of associations [88]. Future studies should pref-
erably use device based measures of physical activity. For 
RCTs, better reporting of randomisation would improve risk 
of selection bias, and standardised reporting of between 
group differences at the end of the trial rather than focussing 
on within group changes would be better practice. Longer 
follow-up time would also indicate the time scale involved 
and if the effects are lasting.
Finally, it is likely that the response to regular physical 
activity will vary between different vaccinations and in dif-
ferent populations. The current body of evidence is too small 
currently to draw specific conclusions. Further studies are 
warranted to understand how physical activity programmes 
could be tailored for specific vaccinations and populations.
4.2  Strengths and Limitations
The strengths of our meta-analysis included: the wide-rang-
ing systematic search strategy; the focus on robust evidence 
obtained from RCTs and prospective studies only; a thor-
ough check for duplicate data; the comprehensive quality 
assessment of the primary studies; the extensive range of 
outcome analysed; and the focus on objectively measured 
outcomes. The main limitation is that we had to combine 
heterogeneous information without being able to pinpoint 
precisely the source of heterogeneity. The meta-analysis of 
laboratory immune parameters focused on cell counts and 
antibody concentration and this does not allow a full under-
standing of the link between changes in the immune system 
and the decrease in risk of infectious disease associated with 
regular physical activity. Finally, the evidence base is not 
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large enough currently to be able to understand more pre-
cisely the impact of time, duration, frequency and intensity 
of physical activity in different populations and for different 
infectious diseases and vaccinations.
5  Conclusion
The results from this systematic review and meta-analysis 
reveal that regular physical activity increases resistance to 
infectious disease in the general population. Regular physi-
cal activity should be promoted in the general population to 
decrease the risk of community-acquired infection and infec-
tious disease mortality, strengthen the potency of immunisa-
tion programmes and help lessen the impact of pandemics 
such as the recent COVID-19.
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